HDAC3 and acute myeloid leukemia: Selective inhibition of FLT3, HDAC3 or HDAC6 have been proved useful for the treatment of acute myeloid leukemias, but the benefits of combinations of HDAC3, HDAC6 and FLT3 inhibitors were rarely reported.